|
FIG4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.577370E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.927800E-02 |
| Normal-vs-Stage2 |
4.879200E-01 |
| Normal-vs-Stage3 |
6.547600E-01 |
| Normal-vs-Stage4 |
4.433600E-01 |
| Stage1-vs-Stage2 |
7.037400E-01 |
| Stage1-vs-Stage3 |
2.452000E-01 |
| Stage1-vs-Stage4 |
5.937600E-01 |
| Stage2-vs-Stage3 |
6.886400E-01 |
| Stage2-vs-Stage4 |
9.289800E-01 |
| Stage3-vs-Stage4 |
7.333000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.411400E-01 |
| Normal-vs-AfricanAmerican |
1.766180E-02 |
| Normal-vs-Asian |
2.425400E-01 |
| Caucasian-vs-AfricanAmerican |
2.744000E-02 |
| Caucasian-vs-Asian |
7.730800E-01 |
| AfricanAmerican-vs-Asian |
6.912000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.104200E-01 |
| Normal-vs-Female |
1.271440E-01 |
| Male-vs-Female |
5.058200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.006300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.960200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.222200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.296200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.138600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.324000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.465800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.885200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.259000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.059800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.373000E-01 |
| Classical-VS-Follicular |
9.043800E-03 |
| Classical-VS-Other |
2.426600E-01 |
| Classical-VS-Normal |
3.880100E-02 |
| Tall-VS-Follicular |
4.091400E-01 |
| Tall-VS-Other |
5.158600E-01 |
| Tall-VS-Normal |
5.254800E-01 |
| Follicular-VS-Other |
9.302200E-01 |
| Follicular-VS-Normal |
6.627400E-01 |
| Other-VS-Normal |
7.147400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.806200E-01 |
| Normal-vs-N1 |
5.158600E-01 |
| N0-vs-N1 |
3.703400E-01 |
|
|
